Market Report Scope Glucagon Like Peptide 1 Analogs Market Report Coverage Uncover macros and micros vetted on 75+ parameters: Get instant access to report Glucagon Like Peptide 1 Analogs Market Dynamics To learn more about this report, Glucagon Like Peptide 1 Analogs Market Driver - Rising Prevalence of Type 2 Diabetes and Obesity The escalating prevalence of type 2 diabetes and obesity worldwide is a significant factor driving the demand for Glucagon Like Peptide 1 (GLP-1) analogs
Pharmacies and health retail chains have enhanced their offerings, while e-commerce has expanded accessibility through direct-to-consumer wellness subscriptions
In addition, in order for these drugs to become a public health tool for cancer treatment or prevention, more information would be necessary such as what cancers are most affected by GLP-1s, how long patients need to remain on therapy for the desired protection and whether benefits differ between different GLP-1 medications
IGF-1 and IGFBP-3: risk of prostate cancer among men in the prostate, lung, colorectal and ovarian cancer screening trial
doi:10.1210/clinem/dgad463 Lin S, Deng Y, Huang J, et al